Ledger.Open graph →
SEC Form D · Amendment · filed April 8, 2020

Woolsey Pharmaceuticals, Inc

Offering
—
Sold
$8.6M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

David M. Geliebter · NEW YORK, NYDirectorSven M. Jacobson · NEW YORK, NYExec · DirectorScott Hutchins · Walpole, MADirectorDingan Fei · Grand Cayman, Cayman IslandsExec · DirectorMelanie P. Dow · New York, NYDirectorDavid P. O'Connor · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗